CVS Health Co. (NYSE:CVS) Shares Purchased by Strengthening Families & Communities LLC

Strengthening Families & Communities LLC grew its position in shares of CVS Health Co. (NYSE:CVS) by 13.3% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 27,218 shares of the pharmacy operator’s stock after acquiring an additional 3,202 shares during the period. Strengthening Families & Communities LLC’s holdings in CVS Health were worth $1,711,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Resurgent Financial Advisors LLC grew its stake in shares of CVS Health by 45.3% in the first quarter. Resurgent Financial Advisors LLC now owns 4,339 shares of the pharmacy operator’s stock valued at $346,000 after buying an additional 1,352 shares in the last quarter. Davis R M Inc. boosted its holdings in CVS Health by 8.7% in the first quarter. Davis R M Inc. now owns 3,010 shares of the pharmacy operator’s stock valued at $240,000 after purchasing an additional 242 shares during the last quarter. Bahl & Gaynor Inc. boosted its holdings in CVS Health by 11.9% in the first quarter. Bahl & Gaynor Inc. now owns 15,833 shares of the pharmacy operator’s stock valued at $1,263,000 after purchasing an additional 1,680 shares during the last quarter. Rockport Wealth LLC bought a new position in CVS Health during the 1st quarter worth approximately $242,000. Finally, O Shaughnessy Asset Management LLC lifted its holdings in CVS Health by 34.9% during the 1st quarter. O Shaughnessy Asset Management LLC now owns 86,556 shares of the pharmacy operator’s stock worth $6,904,000 after buying an additional 22,400 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Performance

Shares of CVS Health stock opened at $53.19 on Monday. The stock has a market cap of $66.93 billion, a PE ratio of 13.50, a price-to-earnings-growth ratio of 0.92 and a beta of 0.55. The business has a fifty day simple moving average of $59.23 and a 200-day simple moving average of $58.60. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12 month low of $52.71 and a 12 month high of $83.25.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. CVS Health’s revenue was up 6.3% compared to the same quarter last year. During the same quarter last year, the firm posted $2.21 earnings per share. On average, sell-side analysts anticipate that CVS Health Co. will post 5.48 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were given a dividend of $0.665 per share. The ex-dividend date was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a yield of 5.00%. CVS Health’s payout ratio is 67.51%.

Wall Street Analysts Forecast Growth

A number of research firms have commented on CVS. Wells Fargo & Company reduced their target price on CVS Health from $61.00 to $60.00 and set an “equal weight” rating on the stock in a report on Monday, November 4th. StockNews.com downgraded CVS Health from a “hold” rating to a “sell” rating in a report on Thursday. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft cut their price target on CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Finally, Evercore ISI raised their price target on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $72.44.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.